The Canadian Paediatric Society

The establishment of paediatric-sensitive national pharmacare is an opportunity to correct the long-standing regulatory neglect that has led to a poor availability of paediatric drugs and child-friendly formulations. We therefore strongly support a pharmacare system that prioritizes the needs of children and youth and upholds the core principles reaffirmed in Bill C-213 of public administration, comprehensiveness, universality, portability and accessibility.